A Multicentric Observational Study on Azilsartan to Assess the Efficacy, Safety and Tolerability in the Management of Hypertension in Indian Population: ZEAL Study
Uday M Jadhav, B C Kalmath, Manjula S & Krishna Kumar M · Asian Journal of Cardiology Research · 2024
Background: Azilsartan is a recently approved angiotensin receptor blocker (ARB) available for the treatment of hypertension in India. Azilsartan has demonstrated unique properties which are different from the previous ARBs. The study objective was to assess the efficacy, safety...
Open access
Research Article